Wirk, Baldeep, and Jin Lim. 2025. “Ruxolitinib Is an Effective Therapy for Ciltacabtagene Autoleucel-Associated Parkinsonism in Multiple Myeloma”. Journal of Hematology 14 (3): 146-51. https://doi.org/10.14740/jh2046.